Pan-Covid study (ends on 31st March 2021)
The Covid-19 outbreak will affect thousands of pregnant women globally and evidence is currently limited on its impact on pregnancy and neonates.
What is the Pan-Covid study?
The study aims to better understand the effects of Covid-19 in women and their babies by compiling a global disease registry focussing on birth outcomes. There is a need to rapidly collect and pool data on pregnant women affected by suspected or confirmed Covid-19 to inform treatment and preventative strategies in this and future outbreaks.
Who can participate?
People aged 18-50 who’ve had Covid-19 symptoms or tested positive during their pregnancy or one month postnatally.
The study will close on the 31st of March 2021.
What will I need to do?
Contact research nurse Gail Castle: firstname.lastname@example.org who will send you more information.
If you wish to participate in the study, you will need to provide your verbal consent to our research nurse who will enter some of your maternity information into a secure database. The information will then be used anonymously.
The details include yours and your baby’s NHS numbers, date of births, the key dates in the pregnancy and information about your health and the outcomes of the pregnancy.
What does the study involve?
Data will be collected from January 2020 and March 2021 focusing on miscarriage, fetal growth restriction and stillbirth, pre-term delivery and potential transmission to the baby. The study will also collect data on ultrasound diagnosis and neonatal care not included in other more general studies. Data entry will be performed by The Trust’s Research Nurse Gail Castle.
What are the possible benefits and risks of participating?
There are no direct benefits or risks of participation, the data gathered will be used to inform treatment and prevention of Covid-19.
What will happen to the results of the research study?
Results of this study will be published on the study website, in medical journals and presented at medical conferences. You will not be identified in any report or publication.
Please contact research nurse Gail Castle: email@example.com who will send you an information leaflet.